• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Daily Swing Trade Archive
    • Income Seeker
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Healthcare

Sound Familiar? Dovish Fed Talk Induces Stock Reversal

The market's reaction to James Bullard's comments this morning is following an all-too-common pattern.
By JAMES "REV SHARK" DEPORRE
Feb 22, 2018 | 10:53 AM EST
Stocks quotes in this article: SGMO, IOVA, AIMT, SRPT, VKTX

For many traders, one of the more annoying aspects of this market for the past 10 years has been how often the central bankers have saved it. It often seems that they are more worried about the price of equities than how healthy it is to create mountains of cheap debt.

This morning we had a prime example of how this works when St. Louis Fed Head, James Bullard, commented that ""The idea that we need to go 100 basis points in 2018, that seems like a lot to me... Everything would have to go just right. The economy would have to surprise on the upside a bunch of times during the year. I'm not sure that's a good way to think about 2018."

That dovish talk reversed the selling that took place over night and has the indices in the green this morning. Quite often these Fed- induced reversals produce some sustained move but market players seem a bit more skeptical this time.

As I discussed in my opening post, the technical condition of the indices is supportive of a bearish view. This reversal today isn't enough to negate that setup. It is likely that the bears are still anxious to press their bets and would probably do so if we take out the opening lows.

Breadth is solid are around 3,900 gainers to 2,300 losers but we only have about 50 new 12-month highs, which is a function of the fact that the indices are still well off their January highs.

The biotechnology sector is leading on my screens with several names that I have often mentioned performing well. Sangamo Therapeutics (SGMO) , Iovance Biotherapeutics (IOVA) , Aimmune Therapeutics (AIMT) and Sarepta Therapeutics (SRPT) are leading. My Stock of the Week, Viking Therapeutics (VKTX) is working on new highs.

Despite the pockets of strength, I see some messy action and not much new as far as setups. I reduced positions Wednesday and don't see much I'm inclined to add today.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.
TAGS: Investing | U.S. Equity | Healthcare | Financial Services | Futures | Markets | How-to | Stocks

More from Healthcare

Two Dividend Stocks I Own and One I'm Looking to Buy

Dave Butler
Feb 13, 2019 3:23 PM EST

These stocks aren't going out of style.

Ventas Is Showing Some Softness Now, Raise Sell Stop Protection

Bruce Kamich
Feb 13, 2019 9:26 AM EST

The company is relying on several building blocks to return to growth.

Evolus Stockholders May Be Frowning in the Short Run

Bruce Kamich
Feb 8, 2019 10:41 AM EST

Shares of the Botox competitor could correct/consolidate after a recent surge.

Centene Splits 2 For 1 Which Changes the Chart Levels but Not the Trends

Bruce Kamich
Feb 7, 2019 9:45 AM EST

With the stock split a fresh look at the split adjusted stock is now in order.

Alphabet's Healthcare Initiative Squares Off With Amazon, Apple

Kevin Curran
Feb 4, 2019 4:03 PM EST

Healthcare is attracting some very healthy competition among mega-cap names.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 04:01 PM EST KEVIN CURRAN

    Pepsi Kicks off 2019 on a Positive Note

    Pepsi's earnings may not have been immaculate, but...
  • 10:08 AM EST BOB LANG

    Rolling up the Arista

    on Tuesday this week I posted a trade idea here an...
  • 08:11 AM EST KEVIN CURRAN

    Pepsi Earnings Call Notes

    As my first article is in edit, here are some sele...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2019 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login